VITAMIN D IN ENDOMETRIOSIS: MECHANISMS AND CLINICAL POTENTIAL – A LITERATURE REVIEW

In: International Journal of Innovative Technologies in Social Science · 2026 · vol. 4(2(50)) · doi:10.31435/ijitss.2(50).2026.5669 · W7170062518
article OA: gold CC0
AI-generated summary by claude@2026-07, 2026-07-25

This review synthesizes evidence showing vitamin D inhibits endometriotic cell proliferation and inflammation via molecular pathways and is associated with lower serum levels in advanced disease, though supplementation trial results vary.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objectives: Endometriosis is a chronic inflammatory condition affecting approximately 10% of women of reproductive age. Recent studies have highlighted vitamin D as a potential immunomodulator influencing disease progression. This review aims to synthesize current evidence regarding the mechanistic links between vitamin D and endometriosis, the correlation of serum 25(OH)D levels with disease severity, and the clinical efficacy of supplementation. Methods: A systematic literature search was conducted using PubMed and the Cochrane Library. The analysis included randomized controlled trials (RCTs), observational studies, and molecular research published within the last eight years. A qualitative narrative synthesis was performed to categorize findings into mechanistic, observational, and interventional themes. Key Findings: Molecular studies demonstrate that vitamin D inhibits endometriotic cell proliferation, inflammation, and angiogenesis by targeting the NF-κB and VEGF pathways. Observational data generally indicate lower serum 25(OH)D levels in women with advanced endometriosis compared to healthy controls. However, clinical supplementation trials yield heterogeneous results; while some RCTs report significant reductions in pelvic pain and inflammatory markers (hs-CRP), others find no statistical superiority over placebo, potentially due to variations in dosage and baseline vitamin D status. Conclusions: Vitamin D serves as a biologically plausible adjunctive therapy for endometriosis. While not a definitive cure, its safety and anti-inflammatory properties justify its use in managing deficiency. Future research should prioritize personalized supplementation protocols considering genetic polymorphisms of the vitamin D receptor.
Full text 9,825 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Objectives

Endometriosis is a chronic inflammatory condition affecting approximately 10% of women of reproductive age. Recent studies have highlighted vitamin D as a potential immunomodulator influencing disease progression. This review aims to synthesize current evidence regarding the mechanistic links between vitamin D and endometriosis, the correlation of serum 25(OH)D levels with disease severity, and the clinical efficacy of supplementation.

Methods

A systematic literature search was conducted using PubMed and the Cochrane Library. The analysis included randomized controlled trials (RCTs), observational studies, and molecular research published within the last eight years. A qualitative narrative synthesis was performed to categorize findings into mechanistic, observational, and interventional themes. Key Findings: Molecular studies demonstrate that vitamin D inhibits endometriotic cell proliferation, inflammation, and angiogenesis by targeting the NF-κB and VEGF pathways. Observational data generally indicate lower serum 25(OH)D levels in women with advanced endometriosis compared to healthy controls. However, clinical supplementation trials yield heterogeneous results; while some RCTs report significant reductions in pelvic pain and inflammatory markers (hs-CRP), others find no statistical superiority over placebo, potentially due to variations in dosage and baseline vitamin D status.

Conclusions

Vitamin D serves as a biologically plausible adjunctive therapy for endometriosis. While not a definitive cure, its safety and anti-inflammatory properties justify its use in managing deficiency. Future research should prioritize personalized supplementation protocols considering genetic polymorphisms of the vitamin D receptor.

References

Marquardt, R. M., Kim, T. H., Shin, J. H., & Jeong, J. W. (2019). Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis? International Journal of Molecular Sciences, 20(15), 3822. https://doi.org/10.3390/ijms20153822 Saunders, P. T. K., & Horne, A. W. (2021). Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell, 184(11), 2807–2824. https://doi.org/10.1016/j.cell.2021.04.041 Tsamantioti, E. S., & Mahdy, H. (2023). Endometriosis. In StatPearls. StatPearls Publishing. Zondervan, K. T., Becker, C. M., Koga, K., Missmer, S. A., Taylor, R. N., & Viganò, P. (2018). Endometriosis. Nature Reviews Disease Primers, 4(1), Article 9. https://doi.org/10.1038/s41572-018-0008-5 Farhangnia, P., Noormohammadi, M., & Delbandi, A. A. (2024). Vitamin D and reproductive disorders: A comprehensive review with a focus on endometriosis. Reproductive Health, 21(1), Article 61. https://doi.org/10.1186/s12978-024-01797-y Jennings, B. S., & Hewison, M. (2025). Vitamin D and endometriosis: Is there a mechanistic link? Cell Biochemistry and Function, 43(1), e70037. https://doi.org/10.1002/cbf.70037 Kalaitzopoulos, D. R., Samartzis, N., Daniilidis, A., Leeners, B., Makieva, S., Nirgianakis, K., Dedes, I., Metzler, J. M., Imesch, P., & Lempesis, I. G. (2022). Effects of vitamin D supplementation in endometriosis: A systematic review. Reproductive Biology and Endocrinology, 20(1), Article 176. https://doi.org/10.1186/s12958-022-01051-9 van Tienhoven, X. A., Ruiz de Chávez Gascón, J., Cano-Herrera, G., Sarkis Nehme, J. A., Souroujon Torun, A. A., Bautista Gonzalez, M. F., Esparza Salazar, F., Sierra Brozon, A., Rivera Rosas, E. G., Carbajal Ocampo, D., & Cabrera Carranco, R. (2025). Vitamin D in reproductive health disorders: A narrative review focusing on infertility, endometriosis, and polycystic ovarian syndrome. International Journal of Molecular Sciences, 26(5), 2256. https://doi.org/10.3390/ijms26052256 Kalaitzopoulos, D. R., Lempesis, I. G., Athanasaki, F., Schizas, D., Samartzis, E. P., Kolibianakis, E. M., & Goulis, D. G. (2020). Association between vitamin D and endometriosis: A systematic review. Hormones, 19(2), 109–121. https://doi.org/10.1007/s42000-019-00166-w AlAshqar, A., Reschke, L., Kirschen, G. W., & Borahay, M. A. (2021). Role of inflammation in benign gynecologic disorders: From pathogenesis to novel therapies. Biology of Reproduction, 105(1), 7–31. https://doi.org/10.1093/biolre/ioab054 Burjiah, A. R., Sa’adi, A., & Widjiati, W. (2022). Vitamin D inhibited endometriosis development in mice model through interleukin-17 modulation. Open Veterinary Journal, 12(6), 956–964. https://doi.org/10.5455/OVJ.2022.v12.i6.23 Ursache, A., Lozneanu, L., Bujor, I. E., Mandici, C. E., Boiculese, L. V., Bausic, A. I. G., Grigore, M., Socolov, D., & Matasariu, D. R. (2024). Vitamin D—the iceberg in endometriosis—review and meta-analysis. Journal of Personalized Medicine, 14(1), 119. https://doi.org/10.3390/jpm14010119 Evangelisti, G., Barra, F., Fichera, M., & Ferrero, S. (2020). Vitamin D and endometriosis: Is there a correlation with disease severity? Clinical and Experimental Reproductive Medicine, 47(3), 233–234. https://doi.org/10.5653/cerm.2019.03342 Xie, B., Liao, M., Huang, Y., Hang, F., Ma, N., Hu, Q., Wang, J., Jin, Y., & Qin, A. (2024). Association between vitamin D and endometriosis among American women: National Health and Nutrition Examination Survey. PLOS ONE, 19(1), e0296190. https://doi.org/10.1371/journal.pone.0296190 Pan, D., Li, P., Dai, X., & Xie, S. (2025). 25-Hydroxyvitamin D and endometriosis: A bidirectional Mendelian randomization study. Reproductive Sciences, 32(3), 693–701. https://doi.org/10.1007/s43032-024-01517-8 Christoforidis, N., Papapanou, M., Michalakis, D., Dimitraki, M., Chatziparasidou, A., & Siristatidis, C. (2025). Effect of vitamin D supplementation on frozen embryo transfer cycle outcomes. Human Fertility, 28(1), 2493251. https://doi.org/10.1080/14647273.2025.2493251 Somigliana, E., Sarais, V., Reschini, M., Ferrari, S., Makieva, S., Cermisoni, G. C., Paffoni, A., Papaleo, E., & Viganò, P. (2021). Single oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: The SUNDRO randomized controlled trial. American Journal of Obstetrics and Gynecology, 225(3), 283.e1–283.e10. https://doi.org/10.1016/j.ajog.2021.04.234 Mehdizadehkashi, A., Rokhgireh, S., Tahermanesh, K., Eslahi, N., Minaeian, S., & Samimi, M. (2021). The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis. Gynecological Endocrinology, 37(7), 640–645. https://doi.org/10.1080/09513590.2021.1878138 Barnard, N. D., Holtz, D. N., Schmidt, N., Kolipaka, S., Hata, E., Sutton, M., Znayenko-Miller, T., Hazen, N. D., Cobb, C., & Kahleova, H. (2023). Nutrition in the prevention and treatment of endometriosis: A review. Frontiers in Nutrition, 10, 1089891. https://doi.org/10.3389/fnut.2023.1089891 Malvezzi, H., Marengo, E. B., Podgaec, S., & Piccinato, C. A. (2020). Endometriosis: Current challenges in modeling a multifactorial disease of unknown etiology. Journal of Translational Medicine, 18(1), Article 311. https://doi.org/10.1186/s12967-020-02471-0 Buggio, L., Somigliana, E., Pizzi, M. N., Dridi, D., Roncella, E., & Vercellini, P. (2019). 25-Hydroxyvitamin D serum levels and endometriosis: Results of a case-control study. Reproductive Sciences, 26(2), 172–177. https://doi.org/10.1177/1933719118766259 Delbandi, A. A., Torab, M., Abdollahi, E., Khodaverdi, S., Rokhgireh, S., Moradi, Z., Heidari, S., & Mohammadi, T. (2021). Vitamin D deficiency as a risk factor for endometriosis in Iranian women. Journal of Reproductive Immunology, 143, 103266. https://doi.org/10.1016/j.jri.2020.103266 Chen, W. C., Cheng, C. M., Liao, W. T., & Chang, T. C. (2022). Urinary biomarkers for detection of clinical endometriosis or adenomyosis. Biomedicines, 10(4), 833. https://doi.org/10.3390/biomedicines10040833 Cho, M. C., Kim, J. H., Jung, M. H., Cho, I. A., Jo, H. C., Shin, J. K., Lee, S. A., Choi, W. J., & Lee, J. H. (2019). Analysis of vitamin D-binding protein (VDBP) gene polymorphisms in Korean women with and without endometriosis. Clinical and Experimental Reproductive Medicine, 46(3), 132–139. https://doi.org/10.5653/cerm.2019.00122 Jafari, M., Khodaverdi, S., Sadri, M., Moradi, Z., Mohammadi, T., Heidari, S., Akhavan Sales, Z., & Delbandi, A. A. (2021). Association between vitamin D receptor (VDR) and vitamin D binding protein (VDBP) gene polymorphisms and endometriosis susceptibility in Iranian women. Reproductive Sciences, 28(12), 3491–3497. https://doi.org/10.1007/s43032-021-00598-z Yarmolinskaya, M., Denisova, A., Tkachenko, N., Ivashenko, T., Bespalova, O., Tolibova, G., & Tral, T. (2021). Vitamin D significance in pathogenesis of endometriosis. Gynecological Endocrinology, 37(sup1), 40–43. https://doi.org/10.1080/09513590.2021.2006516 Downloads Published Issue Section License Copyright (c) 2026 Julia Kurcińska, Szymon Kurciński, Martyna Kudła, Gabriela Zając, Paweł Czechowicz, Justyna Czechowicz, Mikołaj Antkiewicz, Aleksandra Arczyńska-Antkiewicz, Maria Drozd, Paulina Łobaza, Agata Krawczyk, Natalia Pawełczak, Dorota Kołkowicz, Julia Kociuba, Zuzanna Kruczek This work is licensed under a Creative Commons Attribution 4.0 International License. All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles. CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Source provenance

openalex
last seen: 2026-07-29T06:19:52.536310+00:00
License: CC0 · commercial use OK